Wansiri Krankenhaus
| Thailand | Türkei | Österreich | |
| Mohs-Mikrochirurgie | von $2,200 / 81,400฿ | von $2,200 / 81,400฿ | von $4,000 / 148,000฿ |
| Melanom-Operation | von $4,000 / 148,000฿ | von $3,500 / 129,500฿ | von $9,500 / 351,500฿ |
| Immuntherapie mit Keytruda (Pembolizumab) | von $8,000 / 296,000฿ | von $3,300 / 122,100฿ | von $15,000 / 555,000฿ |
| Aktinium-225-Therapie | von $25,000 / 925,000฿ | von $22,955 / 849,335฿ | von $55,000 / 2,035,000฿ |
| Topische Therapie des Melanoms | - | von $1,450 / 53,650฿ | - |
Dr. Ohm Sudchumphae is a regenerative medicine specialist at Panacee Hospital Rama 2 in Bangkok. He holds a Master’s in Clinical Nutrition and Integrative Medicine. Dr. Ohm is currently pursuing a Doctorate in Psychology. He specializes in combining cell therapy, IV nutrition, and medicinal herbology for chronic conditions.
Geschrieben von Veronika Kazina
Die Melanombehandlung in Thailand umfasst die weite lokale Exzision, die Mohs-Chirurgie und die Sentinel-Lymphknotenbiopsie. Internationale Zentren bieten fortschrittliche Immuntherapien mit PD-1-Inhibitoren wie Keytruda an. Gezielte Therapien für BRAF-Mutationen und zellbasierte Optionen wie die NK-Zelltherapie sind ebenfalls verfügbar. Die meisten Krankenhäuser verfügen über eine JCI-Akkreditierung.
Experteneinschätzung von Bookimed: Thailands Infrastruktur ermöglicht schnelle Übergänge zwischen Diagnose und Behandlung. Die meisten JCI-akkreditierten Kliniken in Bangkok führen molekulare Tests und Staging innerhalb von 48 Stunden durch. Diese Geschwindigkeit ist bei aggressiven Melanomfällen entscheidend. Einige Zentren sind zudem auf die Kombination von Standardprotokollen mit regenerativen NK-Zelltherapien spezialisiert.
Patientenkonsens: Patienten heben die Schnelligkeit der diagnostischen Ergebnisse im Vergleich zu ihren Heimatländern hervor. Viele schätzen die gründlichen Erklärungen der Onkologen zu den Nebenwirkungen der Immuntherapie.
Empfohlene thailändische Krankenhäuser für Melanome sind das Bumrungrad International und das Bangkok Hospital. Diese Einrichtungen verfügen über eine Joint Commission International-Akkreditierung für Qualität. Sie nutzen fortschrittliche Diagnoseinstrumente wie PET-CT-Scans. Spezialisierte Zentren wie das Wattanosoth Cancer Hospital konzentrieren sich vollständig auf die Krebsforschung und -versorgung.
Expertenmeinung von Bookimed: Thailändische Onkologiezentren beherbergen oft spezialisierte Unterzentren für Hautkrebs. Bumrungrad betreibt beispielsweise das Horizon Regional Cancer Center. Dieser dedizierte Fokus führt zu höheren Patientenzahlen. Die Ärzte dort sammeln mehr Erfahrung mit komplexen Melanomstadien. Die Wahl dieser spezialisierten Einheiten stellt den Zugang zu multidisziplinären Tumorkonferenzen sicher.
Patientenkonsens: Patienten erwähnen oft, dass das Personal und die Ärzte sehr professionell sind. Sie merken an, dass die Einrichtungen sauber und modern sind. Viele schätzen die Schnelligkeit der diagnostischen Tests in Bangkoker Krankenhäusern. Die persönliche Aufmerksamkeit durch das Pflegepersonal wird in ihren Bewertungen ebenfalls hervorgehoben.
Die Genesung nach einer Melanom-Operation in Thailand dauert in der Regel 1 bis 3 Wochen für die primäre Wundheilung. Die meisten Patienten können 7 bis 10 Tage nach der Operation sicher nach Hause fliegen. Bei Langstreckenflügen ist es oft ratsam, mindestens 14 Tage zu warten, um das Risiko von Blutgerinnseln zu minimieren. Ihr Chirurg muss ein Flugtauglichkeitszeugnis ausstellen.
Bookimed-Experteneinblick: Thailändische Onkologiezentren wie Bumrungrad oder das Bangkok Hospital koordinieren oft fachübergreifende Untersuchungen innerhalb von 48 Stunden. Diese Effizienz hilft internationalen Patienten, die Genesung früher zu beginnen. Unsere Daten zeigen, dass Zentren mit hohem Patientenaufkommen der frühen Mobilität für Reisende Priorität einräumen. Dieser Fokus trägt dazu bei, eine Rate von 95 % bei komplikationsfreien Abreisen aufrechtzuerhalten.
Patientenkonsens: Patienten merken an, dass es wichtig ist, in der ersten Woche in der Nähe der Klinik zu bleiben. Sie betonen oft, dass die Bewältigung von Schwellungen die größte Herausforderung während des Heimflugs darstellt.
Melanoma treatment in Thailand includes surgical excision, immunotherapy with PD-1 inhibitors like Keytruda, and Mohs microsurgery. JCI-accredited hospitals in Bangkok provide these therapies. They also offer Natural Killer (NK) cell therapy and targeted radiopharmaceutical treatments. Centres like Bumrungrad International Hospital often complete staging and molecular testing within 48 hours.
Bookimed Expert Insight: Many Australian patients seek standard surgery, but Thailand offers integrated care. Bumrungrad International Hospital treats over 1,000,000 patients annually. It maintains GHA and JCI accreditations. This high volume allows clinics to offer niche treatments like Natural Killer cell therapy. This combination is rare in smaller regional centres and helps with complex cases.
Patient Consensus: Patients note that prompt specialist assessment and accurate pathology reviews are vital. They highlight the importance of multidisciplinary teams. It is also important to have clear follow-up plans for when they return home.
Specialised immunotherapy and targeted melanoma treatments are widely available in Thailand. Leading Bangkok hospitals offer options like Keytruda and BRAF mutation testing. These facilities maintain high standards through JCI and ISO certifications. This means patients receive care comparable to Australian private hospitals.
Bookimed Expert Insight: While many centres treat general oncology, Bumrungrad International Hospital manages over 1,000,000 patients annually. This massive volume includes international patients from 190 countries. Their experience with complex foreign cases often means smoother logistics for Australians. This includes easier access to English-speaking specialists and streamlined medical records.
Patient Consensus: Patients note that Thailand provides faster access to treatment than many public systems. They suggest confirming specific drug stock and mutation testing availability before flying to Bangkok.
Mohs micrographic surgery is available in Thailand at specialised tertiary hospitals and cancer centres. Fellowship-trained surgeons perform this precise procedure. It reports success rates of 97% to 99%. It remains a primary choice for high-risk melanoma and delicate areas like the face.
Bookimed Expert Insight: Thailand ranks 4th globally for international patient requests in our database. Major hospitals like Bumrungrad International serve 190 countries and prioritise digital health records. This infrastructure helps Australian patients receive seamless follow-up care with their local GP.
Patient Consensus: Patients note it is important to confirm if a clinic uses frozen-section Mohs or staged excision. They suggest getting a written plan covering margin control and pathology before travelling to Thailand.
Melanoma treatment in Thailand typically begins within a few days to two weeks of diagnosis. Hospitals like Bumrungrad International provide molecular testing and staging within 48 hours. This efficiency allows surgeons and oncologists to finalise treatment plans and schedule theatre time almost immediately.
Bookimed Expert Insight: Thailand leads in rapid oncology onboarding. Major centres like Bumrungrad International have 1,300 doctors on-site. This scale eliminates the long waiting lists common in Australia. Patients can often start immunotherapy or surgery in under 5 days if pathology slides are ready.
Patient Consensus: Patients note that bringing original pathology slides and imaging reports from Australia speeds up the process. Same-day specialist consults in Bangkok are common. However, hospitals often require upfront deposits before booking surgery or targeted therapies.
Patients can get a second opinion for melanoma in Thailand at JCI-accredited centres. Specialists offer expert reviews of pathology slides, BRAF gene testing, and staging. Many clinics provide remote consultations. This allows Australians to access oncology expertise and immunotherapy protocols before travelling for treatment.
Bookimed Expert Insight: Thailand ranks 4th globally for patient requests. Bumrungrad International Hospital alone serves 1,000,000 patients annually. This massive volume means Thai oncologists see many advanced melanoma cases. For Australians, this scale helps build expertise in rare or resistant melanoma subtypes.
Patient Consensus: Patients note it is important to request a review of both diagnosis and staging. They recommend bringing pathology slides to Thailand for an independent assessment by a surgical oncologist.
Thailand serves over 1 million international patients annually with melanoma care through JCI-accredited hospitals. Specialist centres provide multidisciplinary treatment including Mohs microsurgery and PET-CT diagnostics. They also offer modern immunotherapies like Keytruda. These facilities use tumour boards to coordinate surgical oncology and pathology services for precise results.
Bookimed Expert Insight: Many Australian patients focus only on major surgical hubs. However, integrative centres like Panacee Hospital Rama 2 offer alternative supportive therapies. These include Oncothermia and cell-based treatments. Combining these with surgery at major Bangkok facilities creates a comprehensive recovery plan. This dual approach helps manage complex stages that standard protocols might not address alone.
Patient Consensus: Patients find it essential to choose hospitals with dedicated oncology teams. They advise against using cosmetic dermatology clinics for melanoma care. Experience shows that checking for in-house histopathology review is vital. Patients also suggest checking that imaging can be sent to Australia for follow-up.
